Latin America Generic drugs market worth USD 67.72 Billion by 2021
The cost-effectiveness of abbreviated drugs has given it a competitive lead over branded drugs in the market. Key driving factor for generic drugs is patent expiry for branded drugs
(EMAILWIRE.COM, December 20, 2017 ) According to the report Latin America Generic drugs market, published by Market Data Forecast, The Market was worth USD 36.04 Billion in 2015 and estimated to reach USD 67.72 Billion by 2021 with a growing potential of 11 %.
Browse market data tables and in-depth TOC of the Latin America Generic drugs to 2021 @ http://www.marketdataforecast.com/market-reports/latin-america-generic-drugs-market-2187/
Generic drugs are also known as abbreviated drugs. Generic Drugs are Equivalent or Bioequivalent to brand name drug in terms of Side effects, Risks, Dosage, Intended use, and Strength. Although they are equivalent to their brand name counterparts, they are sold at a substantially lower price. To sell a generic drug manufacturing company must submit an Abbreviated New Drug Application for approval after the patent of brand name counterpart expires.
Free sample of the report is available @ http://www.marketdataforecast.com/market-reports/latin-america-generic-drugs-market-2187/request-sample
The cost-effectiveness of abbreviated drugs has given it a competitive lead over branded drugs in the market. Key driving factor for generic drugs is patent expiry for branded drugs. Patent for Branded drugs with sales of up to USD 135 billion was expired in 2015. Nearly USD 150 Billion worth of patents for branded drugs will expire by 2020 which will give generic drugs a huge advantage. One more trend which influences market growth is outsourcing. Presence of some key players in this market and developing economies are some driving factors in this region. Vendors are using outsourcing as a strategy to reduce their capital which will be an advantage to generic drugs. Only restraint for this market is rigid rules setup by FDA for approval of these drugs and the threat of counterfeit drugs.
Latin America Generic Drugs Market: Segmentation
• Type
o Biosimilars
o simple generics
o Super generics
o Y-o-Y Growth Analysis, By Product
o Market Attractiveness Analysis, By Product
o Market Share Analysis, By Product
• Therapeutic drugs
o Cardiovascular Products
o Anti-infective Drugs
o Anti Arthritis Drugs
o Central Nervous System Drugs
o Anti Cancer Drugs
o Respiratory System Drugs
o Others
o Y-o-Y Growth Analysis, By Therapeutic Drugs
o Market Attractiveness Analysis, By Therapeutic Drugs
o Market Share Analysis, By Therapeutic Drugs
• Geographical Analysis
o Latin America
o Brazil
o Mexico
Avail Discount @ http://www.marketdataforecast.com/market-reports/latin-america-generic-drugs-market-2187/request-discount
Key players in this market are Ranbaxy Laboratories, Ltd, Actavis, Mylan, Inc., Industries, Ltd., Dr. Reddy’s Laboratories, Par Pharmaceutical, Inc., Sandoz International GmbH, Hospira, Inc., Apotex, Inc., Watson Pharmaceuticals, Ltd., Teva Pharmaceutical and others.
Buy now @ https://www.marketdataforecast.com/cart/buy-now/latin-america-generic-drugs-market-2187
About Market Data Forecast:
The publisher of this report is Market Data Forecast whose forte lies in Market research and Business Intelligence. Handling both individual and corporate clients across multiple business domains they offer syndicated/customized research to suit the client’s research objective. Their research reports section offers a wide variety of market studies ranging from all-encompassing comprehensive market studies to product specific niche markets covering Global among other regions of the global market as well. For more info kindly visit, www.marketdataforecast.com
Browse market data tables and in-depth TOC of the Latin America Generic drugs to 2021 @ http://www.marketdataforecast.com/market-reports/latin-america-generic-drugs-market-2187/
Generic drugs are also known as abbreviated drugs. Generic Drugs are Equivalent or Bioequivalent to brand name drug in terms of Side effects, Risks, Dosage, Intended use, and Strength. Although they are equivalent to their brand name counterparts, they are sold at a substantially lower price. To sell a generic drug manufacturing company must submit an Abbreviated New Drug Application for approval after the patent of brand name counterpart expires.
Free sample of the report is available @ http://www.marketdataforecast.com/market-reports/latin-america-generic-drugs-market-2187/request-sample
The cost-effectiveness of abbreviated drugs has given it a competitive lead over branded drugs in the market. Key driving factor for generic drugs is patent expiry for branded drugs. Patent for Branded drugs with sales of up to USD 135 billion was expired in 2015. Nearly USD 150 Billion worth of patents for branded drugs will expire by 2020 which will give generic drugs a huge advantage. One more trend which influences market growth is outsourcing. Presence of some key players in this market and developing economies are some driving factors in this region. Vendors are using outsourcing as a strategy to reduce their capital which will be an advantage to generic drugs. Only restraint for this market is rigid rules setup by FDA for approval of these drugs and the threat of counterfeit drugs.
Latin America Generic Drugs Market: Segmentation
• Type
o Biosimilars
o simple generics
o Super generics
o Y-o-Y Growth Analysis, By Product
o Market Attractiveness Analysis, By Product
o Market Share Analysis, By Product
• Therapeutic drugs
o Cardiovascular Products
o Anti-infective Drugs
o Anti Arthritis Drugs
o Central Nervous System Drugs
o Anti Cancer Drugs
o Respiratory System Drugs
o Others
o Y-o-Y Growth Analysis, By Therapeutic Drugs
o Market Attractiveness Analysis, By Therapeutic Drugs
o Market Share Analysis, By Therapeutic Drugs
• Geographical Analysis
o Latin America
o Brazil
o Mexico
Avail Discount @ http://www.marketdataforecast.com/market-reports/latin-america-generic-drugs-market-2187/request-discount
Key players in this market are Ranbaxy Laboratories, Ltd, Actavis, Mylan, Inc., Industries, Ltd., Dr. Reddy’s Laboratories, Par Pharmaceutical, Inc., Sandoz International GmbH, Hospira, Inc., Apotex, Inc., Watson Pharmaceuticals, Ltd., Teva Pharmaceutical and others.
Buy now @ https://www.marketdataforecast.com/cart/buy-now/latin-america-generic-drugs-market-2187
About Market Data Forecast:
The publisher of this report is Market Data Forecast whose forte lies in Market research and Business Intelligence. Handling both individual and corporate clients across multiple business domains they offer syndicated/customized research to suit the client’s research objective. Their research reports section offers a wide variety of market studies ranging from all-encompassing comprehensive market studies to product specific niche markets covering Global among other regions of the global market as well. For more info kindly visit, www.marketdataforecast.com
Contact Information:
Market Data Forecast.
Abhishek
Tel: +1-888- 702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Market Data Forecast.
Abhishek
Tel: +1-888- 702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results